Digital Health Approaches for Improved Population Health Outcomes: Time for a Disease Vulnerability Matrix for Individuals and Communities?

by Gaurav Laroia, Cole Zanetti, Cole Zanetti, Vasant Kumar Ramaswamy, Benjamin D. Horne, Benjamin D. Horne, David C. Klonoff, David C. Klonoff, David C. Klonoff, Bobby John
Published 2021-09-01

Continuous Glucose Monitoring in the Hospital

by M. Citlalli Perez-Guzman, Trisha Shang, Jennifer Y. Zhang, Donna Jornsay, David C. Klonoff
Published 2021-04-01

Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing

by David C Klonoff, Stephanie Bassock, Andrea Dwyer, Ella Engels, Marianne Qvist, Thomas Sparre, Soren Snitker
Published 2021-06-01

Effect of Environmental Pollutants PM2.5, CO, NO₂, and O₃ on the Incidence and Mortality of SARS-CoV-2 Infection in Five Regions of the USA

by Sultan Ayoub Meo, Abdulelah Adnan Abukhalaf, Omar Mohammed Alessa, Abdulrahman Saad Alarifi, Waqas Sami, David C. Klonoff
Published 2021-07-01

Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19

by Sultan Ayoub Meo, Thamir Al-Khlaiwi, Adnan Mahmood Usmani, Anusha Sultan Meo, David C. Klonoff, Thanh D. Hoang
Published 2020-06-01

Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries

by Sultan Ayoub Meo, Abdulelah Adnan Abukhalaf, Ali Abdullah Alomar, Faris Jamal AlMutairi, Adnan Mahmood Usmani, David C. Klonoff
Published 2020-11-01

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis

by Sultan Ayoub Meo, Syed Ziauddin A. Zaidi, Trisha Shang, Jennifer Y. Zhang, Thamir Al-Khlaiwi, Ishfaq A. Bukhari, Javed Akram, David C. Klonoff
Published 2020-10-01